Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy

Fondation Ophtalmologique Adolphe de Rothschild250 enrolled

Overview

The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Neuro-Ophthalmology

Interventions

MRIOTHER

Diffusion sequence (8 minutes long) added to the initial MRI

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient over 18 years old * Patient with suspected NOIA, evoked after clinical examination by a specialized ophthalmologist * For which a brain and visual MRI is planned * Express consent to participate in the study * Affiliate or beneficiary of a Social Security scheme Exclusion Criteria: * Contraindication to MRI (electrical device, metallic foreign body, claustrophobia) * Patient benefiting from a legal protection measure * Pregnant or breastfeeding woman

Locations (3)

CHU de LILLE

Lille, Lille, France

NOT_YET_RECRUITING

Fondation A De Rothschild

Paris, PARIS, France

RECRUITING

Chu Rouen

Rouen, France

NOT_YET_RECRUITING

Outcomes

Primary Outcomes

Study the sensitivity of the High resolution Diffusion sequence in the detection of NOIA, evaluated by a DWI hypersignal and an ADC hyposignal of the optic nerve

Time frame: basline

Central Contacts

Amelie YAVCHITZ

CONTACT

0148036431 ayavchitz@for.paris

sidney krystal

CONTACT

0148036401 skrystal@for.paris

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.